TypeZero Technologies

We are thrilled to join the Dexcom family and can't wait to see what the future holds as we work together to help persons with diabetes across the globe.

Dexcom Acquires TypeZero Technologies Dexcom Acquires TypeZero Technologies

We're proud to partner with EOFlow on this exciting and important project.

TypeZero and EOFlow to Develop Closed Loop System Featuring AP Technology and Patch Insulin Pump TypeZero and EOFlow to Develop Closed Loop System Featuring AP Technology and Patch Insulin Pump Press Release - updated: Feb 13, 2018 09:45 EST CHARLOTTESVILLE, Va. and SEOUL, South Korea, February 13, 2018 (Newswire.com) - Digital health company TypeZero Technologies, Inc. and medical device manuf...

Proud to share more exciting news from our partners at Tandem!

Tandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study Timeline Tandem reports successful completion of hybrid closed loop pilot study using t:slim X2 Insulin Pump with TypeZero algorithms and Dexcom G6 CGM.

We're thrilled to continue partnering with our colleagues at UVA on this exciting AP work!

Unafraid to Ask: Artificial Pancreas UVA researchers are revolutionizing diabetes management by asking more of math and medicine. See how their new approach works in this video.

Senseonics and TypeZero Sign Development Agreement for Artificial Pancreas and Decision Support Systems

Senseonics and TypeZero Sign Development Agreement for Artificial Pancreas and Decision Support Systems Senseonics Holdings, Inc. , a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring system for people with diabetes, and TypeZero Technologies, Inc., a personalized diabetes management company, today announce...

Great news!

Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy (NASDAQ:DXCM) (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce that the

Thanks, Google for helping celebrate World Diabetes Day!

We’re thrilled to partner with Tandem and Dexcom in the upcoming IDCL Trial!
http://www.businesswire.com/news/home/20161110005485/en/NIH-funded-International-Diabetes-Closed-Loop-IDCL-Trial

NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine Technologies from Tandem Diabetes Care, Dexcom and TypeZero | Business Wire Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the Unite

Type Zero's Artificial Pancreas Project / Diabetic Dabs - Diabetes Connections The Type Zero Technologies artificial pancreas project is one of the many racing to market. Their technology comes from years of research, still ongoing, at the University of Virginia. This summer, they announced a new partnership with Tandem. Molly McElwee Malloy, who has type 1 herself, is the hea...

Nice write up on the UVA website! https://news.virginia.edu/illimitable/ingenuity/power-artificial-pancreas

Tandem Diabetes Care and TypeZero Technologies Announce License Agreement to Accelerate Development and Commercialization of Closed-Loop Artificial Pancreas System | Business Wire Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of a family of innovative touchscreen insulin pumps, and Typ

Looking forward to ADA next week!

76th Scientific Sessions | American Diabetes Association 76_sci_banner_885x120.jpg The American Diabetes Association’s Scientific Sessions offers researchers and health care professionals from around the world the unique opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care. Over the course of five d...